This threshold was chosen based on the magnitude of the AUC peak corresponding to loss of the CDKN2A/B locus on chromosome 9p, a molecular feature that is sufficient for diagnosis of anaplastic meningioma, WHO grade 310. The gene discussed is CDKN2A; the disease is anaplastic meningioma.